Feature visualization and classification for the discrimination between individuals with Parkinson’s disease under levodopa and DBS treatments

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1475-925X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Feature visualization and classification for the discrimination between individuals with Parkinson’s disease under levodopa and DBS treatments ; volume:15 ; number:1 ; day:30 ; month:12 ; year:2016 ; pages:1-22 ; date:12.2016
Biomedical engineering online ; 15, Heft 1 (30.12.2016), 1-22, 12.2016

Schlagwort
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit

Urheber
Machado, Alessandro R. P.
Beteiligte Personen und Organisationen
Zaidan, Hudson Capanema
Paixão, Ana Paula Souza
Cavalheiro, Guilherme Lopes
Oliveira, Fábio Henrique Monteiro
Júnior, João Areis Ferreira Barbosa
Naves, Kheline
Pereira, Adriano Alves
Pereira, Janser Moura
Pouratian, Nader
Zhuo, Xiaoyi
O’Keeffe, Andrew
Sharim, Justin
Bordelon, Yvette
Yang, Laurice
Vieira, Marcus Fraga
Andrade, Adriano O.
SpringerLink (Online service)

DOI
10.1186/s12938-016-0290-y
URN
urn:nbn:de:1111-201701282030
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:54 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Machado, Alessandro R. P.
  • Zaidan, Hudson Capanema
  • Paixão, Ana Paula Souza
  • Cavalheiro, Guilherme Lopes
  • Oliveira, Fábio Henrique Monteiro
  • Júnior, João Areis Ferreira Barbosa
  • Naves, Kheline
  • Pereira, Adriano Alves
  • Pereira, Janser Moura
  • Pouratian, Nader
  • Zhuo, Xiaoyi
  • O’Keeffe, Andrew
  • Sharim, Justin
  • Bordelon, Yvette
  • Yang, Laurice
  • Vieira, Marcus Fraga
  • Andrade, Adriano O.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease

Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease

Modulatory Effects of Levodopa on Cerebellar Connectivity in Parkinson’s Disease

Gut bacterial deamination of residual levodopa medication for Parkinson’s disease

Gut bacterial deamination of residual levodopa medication for Parkinson’s disease

Embelin and levodopa combination therapy for improved Parkinson’s disease treatment

Embelin and levodopa combination therapy for improved Parkinson’s disease treatment

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease

Genetic meta-analysis of levodopa induced dyskinesia in Parkinson’s disease

Tiefe Hirnstimulation (DBS) beim idiopathischen Parkinson-Syndrom

Tiefe Hirnstimulation (DBS) beim idiopathischen Parkinson-Syndrom

How I do it — asleep DBS placement for Parkinson’s disease

How I do it — asleep DBS placement for Parkinson’s disease

Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability

Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson’s Disease

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease

Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease

Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response

Charakteristika der Unified Parkinson’s Disease Rating Scale im Rahmen der Levodopa-Response

Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs

Long-term treatment of Parkinson’s disease with levodopa and other adjunctive drugs

Verbundene Objekte